Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PAYX | Simmons Christopher C | VP, Controller & Treasurer | 17.07.2026 | Verkauf | 115,92 | 2.615 | 303.131 | Form 4 |
| PAYO | Ordonez Beatrice | Chief Financial Officer | 16.07.2026 | Steuer-Abgabe | 7,09 | 60.485 | 428.839 | Form 4 |
| PAYS | Herman Joan M | EVP, Operations | 16.07.2026 | Verkauf | 8,69 | 28.000 | 243.410 | Form 4 |
| PAYX | Gibson John B | President and CEO | 15.07.2026 | Zuteilung | — | 14.318 | — | Form 4 |
| PAYX | Gibson John B | President and CEO | 15.07.2026 | Steuer-Abgabe | 110,00 | 14.083 | 1.549.130 | Form 4 |
| PAYX | Bergstrom Ryan Norman | Chief Product Officer | 15.07.2026 | Zuteilung | — | 3.409 | — | Form 4 |
| PAYX | Bergstrom Ryan Norman | Chief Product Officer | 15.07.2026 | Steuer-Abgabe | 110,00 | 303 | 33.330 | Form 4 |
| PAYX | Argiropoulos Mason | VP, Chief HR Officer | 15.07.2026 | Zuteilung | — | 2.182 | — | Form 4 |
| PAYX | Argiropoulos Mason | VP, Chief HR Officer | 15.07.2026 | Steuer-Abgabe | 110,00 | 386 | 42.460 | Form 4 |
| PAYX | Parodi Chad C | SVP, HCM, PEO & Insurance | 15.07.2026 | Zuteilung | — | 2.727 | — | Form 4 |
| PAYX | Parodi Chad C | SVP, HCM, PEO & Insurance | 15.07.2026 | Steuer-Abgabe | 110,00 | 300 | 33.000 | Form 4 |
| PAYX | Simmons Christopher C | VP, Controller & Treasurer | 15.07.2026 | Zuteilung | — | 1.818 | — | Form 4 |
| PAYX | Simmons Christopher C | VP, Controller & Treasurer | 15.07.2026 | Steuer-Abgabe | 110,00 | 1.172 | 128.920 | Form 4 |
| PAYX | Ante Adam Brooks | Sr. Vice President, Paycor | 15.07.2026 | Zuteilung | — | 3.409 | — | Form 4 |
| PAYX | Ante Adam Brooks | Sr. Vice President, Paycor | 15.07.2026 | Steuer-Abgabe | 110,00 | 299 | 32.890 | Form 4 |
| PAYX | Bhandari Prabha S | Chief Legal Officer, Secretary | 15.07.2026 | Steuer-Abgabe | 110,00 | 282 | 31.020 | Form 4 |
| PAYX | Roaldsen Elizabeth | Sr. Vice President | 15.07.2026 | Steuer-Abgabe | 110,00 | 2.383 | 262.130 | Form 4 |
| PAYX | Schrader Robert L. | Sr. VP, CFO | 15.07.2026 | Zuteilung | — | 4.364 | — | Form 4 |
| PAYX | Schrader Robert L. | Sr. VP, CFO | 15.07.2026 | Steuer-Abgabe | 110,00 | 2.382 | 262.020 | Form 4 |
| PAYS | Herman Joan M | EVP, Operations | 15.07.2026 | Verkauf | 8,60 | 31.904 | 274.253 | Form 4 |
| PAYX | Mucci Martin | Director | 14.07.2026 | Verkauf | 109,93 | 25.000 | 2.748.250 | Form 4 |
| PAYX | Mucci Martin | Director | 14.07.2026 | Steuer-Abgabe | 109,92 | 163.329 | 17.953.124 | Form 4 |
| PAYX | Mucci Martin | Director | 14.07.2026 | Optionsausübung | 57,24 | 214.482 | 12.276.950 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 30.06.2026 | Steuer-Abgabe | 8,19 | 11.579 | 94.832 | Form 4 |
| PAYS | Mina Bruce A | Director | 11.06.2026 | Verkauf | 7,10 | 10.000 | 70.950 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 01.06.2026 | Verkauf | 7,80 | 3.000 | 23.400 | Form 4 |
| PAYS | Mina Bruce A | Director | 01.06.2026 | Verkauf | 7,10 | 10.000 | 71.000 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 29.05.2026 | Verkauf | 7,30 | 10.000 | 73.020 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 22.05.2026 | Steuer-Abgabe | 6,72 | 50.681 | 340.576 | Form 4 |
| PAYS | Cunningham Bradley Kramer | Chief Technology Officer | 18.05.2026 | Steuer-Abgabe | 5,87 | 12.369 | 72.544 | Form 4 |
| PAYS | Triplett Dennis L | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Newman Jeffrey B | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Henry Daniel R | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 31.03.2026 | Steuer-Abgabe | 5,90 | 38.664 | 228.118 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 03.02.2026 | Verkauf | 4,16 | 15.057 | 62.637 | Form 4 |
| PAYS | Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | 13.11.2025 | Zuteilung | — | 233.333 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 19.03.2025 | Zuteilung | — | 500.000 | — | Form 4 |
| PAYS | Ngo Michael C | Chief Innovation Officer | 19.03.2025 | Zuteilung | — | 2.500.000 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).